Home

Wayne Weisman

CIK 1602327 · last filed 2024-04-08

Wayne Weisman is a corporate insider who has filed 44 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for SCTL, was dated Apr 8, 2024. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history. 22 SEC filings were submitted jointly with Recro Pharma, Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

44

Lifetime Open-Market Net

-$2.51M

Filer Profile

Reported Address
490 LAPP ROAD
MALVERN, PA 19355
Related Filers
Recro Pharma, Inc. — 22 joint filings, latest 2024-04-08
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Societal CDMO, Inc. (SCTL) Delisted Director 73,620 $1.10 $81.0K $25.0K 4 2024-04-08
Lifeward Ltd. (RWLK) Delisted Director 50,000 $1.05 $52.5K -$2.14M 19 2022-08-03
Baudax Bio, Inc. (BXRX) Delisted Director 1,074 $0.02 $23 $22.9K 5 2022-06-17
Societal CDMO, Inc. (REPH) Delisted Director 2,441,230 $2.09 $5.10M -$415.6K 16 2021-05-17

Recent Filings

44 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-04-08 Societal CDMO, Inc. (SCTL) Delisted Mixed −308,602 -$339.5K EDGAR
2023-08-28 Societal CDMO, Inc. (SCTL) Delisted Buy (P) +62,500 $25.0K EDGAR
2023-05-19 Societal CDMO, Inc. (SCTL) Delisted Grant (A) +73,620 $0 EDGAR
2022-08-03 Lifeward Ltd. (RWLK) Delisted Grant (A) +50,000 $0 EDGAR
2022-06-17 Baudax Bio, Inc. (BXRX) Delisted Grant (A) +39,473 $0 EDGAR
2022-05-20 Societal CDMO, Inc. (SCTL) Delisted Grant (A) +87,500 $0 EDGAR
2021-11-19 Lifeward Ltd. (RWLK) Delisted Sell (S) −4,129 -$6.3K EDGAR
2021-05-27 Lifeward Ltd. (RWLK) Delisted Grant (A) +13,888 $0 EDGAR
2021-05-24 Lifeward Ltd. (RWLK) Delisted Grant (A) +20,833 $0 EDGAR
2021-05-17 Societal CDMO, Inc. (REPH) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 44
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.